200,000+ products from a single source!
sales@angenechem.com
123942-04-1 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(2,6-dimethyl-4-pyridinyl)-6-fluoro-1,4-dihydro-4-oxo-
CAS No: 123942-04-1 Catalog No: AG000L9G MDL No:
Product Description
Catalog Number:
AG000L9G
Chemical Name:
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(2,6-dimethyl-4-pyridinyl)-6-fluoro-1,4-dihydro-4-oxo-
CAS Number:
123942-04-1
Molecular Formula:
C20H17FN2O3
Molecular Weight:
352.3590
IUPAC Name:
1-cyclopropyl-7-(2,6-dimethylpyridin-4-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
InChI:
InChI=1S/C20H17FN2O3/c1-10-5-12(6-11(2)22-10)14-8-18-15(7-17(14)21)19(24)16(20(25)26)9-23(18)13-3-4-13/h5-9,13H,3-4H2,1-2H3,(H,25,26)
InChI Key:
FNKLCGHPPNAPBJ-UHFFFAOYSA-N
SMILES:
Cc1nc(C)cc(c1)c1cc2c(cc1F)c(=O)c(cn2C1CC1)C(=O)O
Properties
Complexity:
623
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
352.122g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
352.365g/mol
Monoisotopic Mass:
352.122g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
70.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4
Literature
| Title | Journal |
|---|---|
| In-vitro activities of quinolones against mycobacteria. | The Journal of antimicrobial chemotherapy 19931201 |
| Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. | Antimicrobial agents and chemotherapy 19921001 |
| CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum. | Diagnostic microbiology and infectious disease 19920201 |
| In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis. | Tubercle 19910901 |
| Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273. | Antimicrobial agents and chemotherapy 19910701 |
| Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent. | Antimicrobial agents and chemotherapy 19900601 |
| MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. | Antimicrobial agents and chemotherapy 19900501 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.